Home › Funds › Castleview Partners, LLC › ELV
Castleview Partners, LLC position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Castleview Partners, LLC reported holding 4,972 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.85% of its reported portfolio and ranking #25 among its reported holdings. Castleview Partners, LLC has disclosed ELV holdings in 10 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-10-10 · Source: SEC EDGAR Form 13F-HR
How Castleview Partners, LLC's ELV position evolved
Castleview Partners, LLC first disclosed a stake in ELV in Q1 2024 at 2 shares (US$1K). The position peaked in Q3 2025 at 6,643 shares, worth US$2.1M. Across 10 filings, Castleview Partners, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,972 shares valued at US$1.9M — an increase of 269 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2025 (shares fell 10% over the following quarter), a 87% increase in Q3 2025 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2 | $1.04K | New |
| Q2 2024 | 2 | $1.08K | Hold |
| Q4 2024 | 2.33K | $850.92K | New |
| Q1 2025 | 3.17K | $1.38M | Add |
| Q2 2025 | 3.56K | $1.38M | Add |
| Q3 2025 | 6.64K | $2.15M | Add |
| Q4 2025 | 5.41K | $1.90M | Reduce |
| Q1 2026 | 5.06K | $1.48M | Reduce |
| Q2 2026 | 4.70K | $1.82M | Reduce |
| Q3 2026 | 4.97K | $1.93M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on Castleview Partners, LLC
FAQ
How long has Castleview Partners, LLC held ELV?
Castleview Partners, LLC has disclosed ELV holdings in 10 of the last 11 reported quarters, going back to Q1 2024.
What is Castleview Partners, LLC's current position in ELV?
As of Q3 2026, Castleview Partners, LLC holds 4.97K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $1.93M, representing 0.85% of its reported portfolio and ranking #25.
Has Castleview Partners, LLC been buying or selling ELV?
In the latest 13F filing (Q3 2026), Castleview Partners, LLC increased its position in ELV. The position peaked in Q3 2025 at 6.64K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.